- Report
- September 2022
- 74 Pages
Mexico
From €3037EUR$3,350USD£2,627GBP
- Report
- April 2023
- 115 Pages
Global
From €4306EUR$4,750USD£3,725GBP
- Report
- August 2022
- 115 Pages
Global
From €4306EUR$4,750USD£3,725GBP
- Report
- April 2023
- 147 Pages
Global
From €4487EUR$4,949USD£3,881GBP
- Report
- June 2023
- 76 Pages
Africa, Middle East
From €1360EUR$1,500USD£1,176GBP
- Report
- February 2020
- 163 Pages
Global
From €13594EUR$14,995USD£11,760GBP
- Report
- May 2024
- 160 Pages
Global
From €4505EUR$4,969USD£3,897GBP
- Report
- June 2023
- 22 Pages
Global
€11105EUR$12,250USD£9,607GBP
- Report
- February 2023
- 27 Pages
Global
€11105EUR$12,250USD£9,607GBP
- Report
- January 2023
- 31 Pages
Global
€11105EUR$12,250USD£9,607GBP
- Report
- January 2023
- 27 Pages
Global
€11105EUR$12,250USD£9,607GBP
- Report
- March 2021
- 48 Pages
Global
€19944EUR$22,000USD£17,254GBP
- Report
- April 2018
United States
From €7248EUR$7,995USD£6,270GBP
- Report
- May 2023
- 78 Pages
Global
From €3500EUR$4,136USD£3,134GBP
- Report
- September 2022
- 60 Pages
Global
From €1813EUR$2,000USD£1,569GBP

Rituximab is a monoclonal antibody used to treat a variety of immune disorders, including rheumatoid arthritis, systemic lupus erythematosus, and non-Hodgkin's lymphoma. It works by targeting and destroying B-cells, which are a type of white blood cell involved in the body's immune response. Rituximab is administered intravenously and is often used in combination with other drugs.
Rituximab is a relatively new drug, having been approved by the US Food and Drug Administration in 1997. Since then, it has become a popular treatment for immune disorders, due to its effectiveness and relatively low side effects. It is also used off-label to treat a variety of other conditions, such as multiple sclerosis and vasculitis.
The market for rituximab is highly competitive, with several major pharmaceutical companies producing the drug. These include Roche, Merck, Pfizer, and Biogen. Additionally, there are several generic versions of the drug available, produced by companies such as Sandoz and Teva Pharmaceuticals. Show Less Read more